Vizsla Silver Corp. (TSX: VZLA) (NYSE: VZLA) (Frankfurt: 0G3) ("Vizsla Silver" or the "Company") is pleased to provide a year-end summary of its activities at its flagship Panuco silver-gold property ...
GSK has agreed to acquire RAPT Therapeutics in a transaction valued at approximately $2.2 billion, adding ozureprubart, a phase IIb long-acting anti-IgE antibody for food allergy prevention, to its ...
Nutrition Education, Basic Schools in Ghana, School Health Policy, Critical Curriculum, Health Belief Model, Social Cognitive Theory Share and Cite: Abor-Adjei, F. (2026) Barriers to Effective ...
GSK and Shionogi have agreed with Pfizer to restructure ViiV Healthcare’s shareholder base, with Shionogi replacing Pfizer’s 11.7 percent economic interest and increasing its stake to 21.7 percent, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback